Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Cormorant Asset Management, LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/10/2023 SC 13G Cormorant Asset Management, LP reports a 5.5% stake in Marinus Pharmaceuticals, Inc.
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 74,911 shares @ $57.37, valued at $4.3M
Bought 150,487 shares @ $57.252, valued at $8.6M
Bought 67,814 shares @ $57.3188, valued at $3.9M
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.
Txns: Granted 6,989 options to buy @ $38.9, valued at $271.9k
06/08/2023 3 Cormorant Asset Management, LP (See below) has filed a Form 3 on GreenLight Biosciences Holdings, PBC
04/24/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.
Txns: Bought 400,000 shares @ $30, valued at $12M
03/16/2023 4 Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.
Txns: Bought 250,000 shares @ $9.9531, valued at $2.5M
Bought 250,000 shares @ $10.5955, valued at $2.6M
Bought 500,000 shares @ $10.1485, valued at $5.1M
03/13/2023 3 Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ambrx Biopharma Inc.
03/13/2023 SC 13G/A Cormorant Asset Management, LP reports a 17.7% stake in Ambrx Biopharma Inc.
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8.4% stake in Elevation Oncology, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 9.2% stake in Design Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.1% stake in GreenLight Biosciences Holdings, PBC
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8.7% stake in Immuneering Corporation
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6% stake in Ambrx Biopharma Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6% stake in Monte Rosa Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8% stake in BioAtla, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8% stake in Aerovate Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.8% stake in Cabaletta Bio, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 4.7% stake in Arcellx, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 5.2% stake in Olema Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 5.3% stake in Altimmune, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 2.7% stake in Viridian Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 10% stake in Longboard Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.5% stake in Tarsus Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.3% stake in Astria Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 4% stake in VectivBio Holding AG
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy